{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T05:16:39Z","timestamp":1675487799964},"reference-count":3,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.2169\/internalmedicine.0379-22","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T22:11:25Z","timestamp":1657750285000},"page":"493-493","source":"Crossref","is-referenced-by-count":0,"title":["Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers"],"prefix":"10.2169","volume":"62","author":[{"given":"Patrick","family":"Sch\u00f6ffski","sequence":"first","affiliation":[{"name":"Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakamura H, Takeda K, Emori M, Hayasaka N, Sugita S. Complete response to eribulin in a patient with unresectable liposarcoma: a case report and implications of new biomarkers. Intern Med 61: 3617-3621, 2022.","DOI":"10.2169\/internalmedicine.9423-22"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sch\u00f6ffski P, Chawla S, Maki RG, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387: 1629-1637, 2016.","DOI":"10.1016\/S0140-6736(15)01283-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Demetri GD, Sch\u00f6ffski P, Grignani G, et al. Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine. J Clin Oncol 35: 3433-3439, 2017.","DOI":"10.1200\/JCO.2016.71.6605"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_0379-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:26:12Z","timestamp":1675481172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_0379-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":3,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0379-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"0379-22"}}